Tag Archives: Alzheimer’s Research and Therapy

Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)

Posted on October 18, 2018 by

Summary Early evening headlines yesterday, on BBC Radio 4 news, announced the “shocking” news that drugs for Alzheimer’s Disease / dementia had been de-listed in France. This story has not been followed-up, and appears to have been dropped quietly; although … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

More On the Association Between Periodontitis and the Risk of Developing Alzheimer’s Disease (NHS Choices / Alzheimer’s Research and Therapy)

Posted on August 25, 2017 by

Summary Analysis of data from the National Health Insurance Research Database (NHIRD) of Taiwan indicates that patients with chronic gum disease (periodontitis) are at higher risk of developing Alzheimer’s Disease. “These findings highlight the need to prevent progression of periodontal disease… … Continue reading →

Posted in For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment